Evidence map›Paper›PMID 42140974›Full record

ArticleNature communications2026

Filamentous morphology of influenza A virus confers enhanced stability in aerosols.

Lu Liu, Ghislain Motos, Céline Terrettaz, Sarah Peterl, Josephine von Kempis, Marie O Pohl, Umut Karakus, Elisabeth Gaggioli, Beiping Luo, Ulrich K Krieger and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lu LiuInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Ghislain MotosLaboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil & Environmental Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Céline TerrettazLaboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil & Environmental Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Sarah PeterlDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8082-3546
Josephine von KempisInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0006-4404-4509
Marie O PohlInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Umut KarakusInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Elisabeth GaggioliInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Beiping LuoInstitute for Atmospheric and Climate Science, ETH Zurich, Zürich, Switzerland.
Ulrich K KriegerInstitute for Atmospheric and Climate Science, ETH Zurich, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-4958-2657
Thomas PeterInstitute for Atmospheric and Climate Science, ETH Zurich, Zürich, Switzerland.
Petr ChlandaDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7782-2139
Tamar KohnLaboratory of Environmental Virology, School of Architecture, Civil & Environmental Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-0395-6561
Athanasios NenesLaboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil & Environmental Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-3873-9970
Silke StertzInstitute of Medical Virology, University of Zurich, Zurich, Switzerland. stertz.silke@virology.uzh.ch.ORCID http://orcid.org/0000-0001-9491-2892

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 240245660-SFB1129Deutsche Forschungsgemeinschaft (German Research Foundation) 537227910Deutsche Forschungsgemeinschaft (German Research Foundation) 537419712Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSII5_189939Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) IC00I0-228106
6 · The paper itself

Abstract

Airborne transmission of influenza A virus (IAV) poses significant challenges to public health. However, the mechanisms governing viral inactivation in aerosols remain poorly understood. IAVs exhibit morphological variability, ranging from 100 nm spherical virions to micrometer-long filaments, depending on strain and growth conditions. Although virion morphology was shown to influence transmissibility, the mechanisms of how morphology affects airborne transmission are yet to be delineated. Here, we investigated the impact of virion shape on IAV stability in bulk solutions and an aerosol system with a focus on particles in the submicrometer range to examine how physicochemical aerosol properties, such as elevated solute concentration and low pH, affect infectivity. We show that filamentous viruses exhibit enhanced stability in aerosol particles at 80% relative humidity (RH) and in bulk solution mimicking increased salinity at this RH. Similarly, filamentous viruses exhibited slower decay under acidic conditions, both in bulk solutions and in acidified aerosol particles. Using primary human airway cultures, we further found that filamentous IAVs possess an infectivity advantage under mucosal immune pressures, including neutralizing antibodies and mucus. These results reveal that filamentous shape provides IAV with enhanced stability under diverse environmental conditions in the aerosol phase and increased infectivity in the respiratory epithelium.

Indexed as

Influenza A virusInfluenza, HumanVirionAerosolsAnimalsAntibodies, NeutralizingDogsHumansHumidityHydrogen-Ion ConcentrationVirus InactivationAerosolsAntibodies, Neutralizing

Identifiers

PMID42140974
PMCPMC13376898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.